Prime

Drugs firm to spend Sh3bn on Nairobi plant expansion

Dawa Limited's GM Sales and Marketing Sunil kumar (left) and managing director Ajay Patel. PHOTO | CHARLES KAMAU | NMG

By  JAMES KARIUKI

Human and animal drugs maker, Dawa Limited, is set to spend Sh3 billion on construction of a new factory and installation of machinery at its Nairobi plant.

The firm’s managing director, Dr Ajay Patel, says the expansion will enable the manufacturer to serve 10 markets in East and West Africa.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.

Get it First!

Stay up to date on the editors' picks of the week.

Latest

  1. PRIME Why Kenya is unlikely to ink a new IMF deal before 2027 polls

  2. PRIME How organisations can mitigate losses with climate risk assessment

  3. PRIME Affordable credit: Kenya’s impact debt opportunity hiding in plain sight

  4. PRIME From M-Pesa pioneer to Absa boss: The rise of Sitoyo Lopokoiyit

In the headlines

View All